Career history of Heng Hsin Tang
Former positions of Heng Hsin Tang
| Companies | Position | Start | End |
|---|---|---|---|
| TBG DIAGNOSTICS LIMITED | Director/Board Member | 12/11/2009 | 15/03/2015 |
| Chief Executive Officer | 11/07/2013 | 27/07/2014 | |
| Independent Dir/Board Member | 21/03/2011 | 18/07/2013 | |
PharmaSynth Pty Ltd.
 PharmaSynth Pty Ltd. Pharmaceuticals: MajorHealth Technology PharmaSynth Pty Ltd. develops drugs and provides contract manufacturing services. The firm’s services include biopharmaceutical contract manufacturing, GMP manufacture of recombinant proteins and vaccines, microbial products, small molecule synthesis for human and veterinary use, synthetic organic chemistry, production of GMP material for pre-clinical studies and clinical trial material batches for Phase 1, 2 and 3 clinical studies. The company was founded in 2009 and is headquartered in Darra, Australia. | Chief Executive Officer | 13/05/2014 | 15/03/2015 |
Training of Heng Hsin Tang
| The University of Queensland | Masters Business Admin |
Statistics
International
| Australia | 4 |
Operational
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
PharmaSynth Pty Ltd.
PharmaSynth Pty Ltd. Pharmaceuticals: MajorHealth Technology PharmaSynth Pty Ltd. develops drugs and provides contract manufacturing services. The firm’s services include biopharmaceutical contract manufacturing, GMP manufacture of recombinant proteins and vaccines, microbial products, small molecule synthesis for human and veterinary use, synthetic organic chemistry, production of GMP material for pre-clinical studies and clinical trial material batches for Phase 1, 2 and 3 clinical studies. The company was founded in 2009 and is headquartered in Darra, Australia. | Health Technology |
- Stock Market
- Insiders
- Heng Hsin Tang
- Experience
